Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if treatment with intrahepatic chemotherapy is a good
options in patients with liver metastases. If the patients have colorectal cancer and never
had got chemotherapy the investigators will use oxaliplatin together with capecitabine. If
the patient is K-RAS wild type the investigators will add cetuximab. In patients who had
received oxaliplatin or in patients with other cancers the investigators will use mitomycin
and gemcitabine together with capecitabine.